Cited by 245Gut microbiota and healthHematopoietic Stem Cell TransplantationNeutropenia and Cancer Infections

Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation

Open access
Weber, Daniela, Jenq, Robert R., Peled, Jonathan U., Taur, Ying, Hiergeist, Andreas, Koestler, Josef, Dettmer, Katja, Weber, Markus +8 more·2017·Biology of Blood and Marrow Transplantation

Abstract

In allogeneic stem cell transplantation (ASCT), systemic broad-spectrum antibiotics are frequently used for treatment of infectious complications, but their effect on microbiota composition is still poorly understood. This retrospective analysis of 621 patients who underwent ASCT at the University Medical Center of Regensburg and Memorial Sloan Kettering Cancer Center in New York assessed the impact of timing of peritransplant antibiotic treatment on intestinal microbiota composition as well as transplant-related mortality (TRM) and overall survival. Early exposure to antibiotics was associated with lower urinary 3-indoxyl sulfate levels (P < .001) and a decrease in fecal abundance of commensal Clostridiales (P = .03) compared with late antibiotic treatment, which was particularly significant (P = .005) for Clostridium cluster XIVa in the Regensburg group. Earlier antibiotic treatment before ASCT was further associated with a higher TRM (34%, 79/236) compared with post-ASCT (21%, 62/297, P = .001) or no antibiotics (7%, 6/88, P < .001). Timing of antibiotic treatment was the dominant independent risk factor for TRM (HR, 2.0; P ≤ .001) in multivariate analysis besides increase age (HR, 2.15; P = .004), reduced Karnofsky performance status (HR, 1.47; P = .03), and female donor-male recipient sex combination (HR, 1.56; P = .02) A competing risk analysis revealed the independent effect of early initiation of antibiotics on graft-versus-host disease-related TRM (P = .004) in contrast to infection-related TRM and relapse (not significant). The poor outcome associated with early administration of antibiotic therapy that is active against commensal organisms, and specifically the possibly protective Clostridiales, calls for the use of Clostridiales-sparing antibiotics and rapid restoration of microbiota diversity after cessation of antibiotic treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbmt.2017.02.006

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Weber, D., Jenq, R. R., Peled, J. U., Taur, Y., Hiergeist, A., Koestler, J., Dettmer, K., Weber, M., Wolff, D., Hahn, J., Pamer, E. G., Herr, W., Gessner, A., Oefner, P. J., van den Brink, M. R. M., & Holler, E.
Affiliations
  • University Hospital Regensburg (DE)
  • The University of Texas MD Anderson Cancer Center (US)
  • Memorial Sloan Kettering Cancer Center (US)
  • Institute of Medical Microbiology and Hygiene (DE)
  • University of Regensburg (DE)
Corresponding author
Weber, Daniela
Venue
Biology of Blood and Marrow Transplantation
Publisher
Elsevier BV
Published
2017-05
Volume
23
Issue
5
Pages
845-852
ISSN
1083-8791 (ISSN-L)
OpenAlex
W2589011865
Cited by
245
References
34
Citations by year
2026: 20 · 2025: 22 · 2024: 23 · 2023: 20 · 2022: 20 · 2021: 37 · 2020: 34 · 2019: 29 · 2018: 28 · 2017: 11 · 2012: 1
FWCI
11.40
Type
journal article
Language
en
Open access
Locations
  • Transplantation and Cellular Therapy (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
Funders
  • German Research Foundation (DFG, KFO's 234, 262)
  • the Regensburg Center for Interventional Immunology, the Marie Curie Initial Training Network Celleurope, the ReForM program of the Regensburg School of Medicine, the National Institutes of Health (R01-HL124112, R01-HL069929, R01-AI080455, R01-AI101406, P01-CA023766)
  • Project 4 (P01-CA023766, P30-CA008748, R01-AI042135, R01-AI095706, K23-AI095398)
  • U.S National Institute of Allergy and Infectious Diseases (HHSN272200900059C)
  • Mr. William H. Goodwin and Mrs. Alice Goodwin
  • The Lymphoma Foundation
  • Alex's Lemonade Stand
  • The Geoffrey Beene Cancer Research Center at Memorial Sloan Kettering Cancer Center
  • The Susan and Peter Solomon Divisional Genomics Program
  • the Lucille Castori Center for Microbes, Inflammation, and Cancer, and the Tow Foundation
  • European Union's Seventh Programme for research, technological development and demonstration (602587)
  • German José Carreras Foundation (DJCLS R 11/09)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
Keywords
allogeneic stem cell transplantation, broad-spectrum antibiotics, gut microbiota, timing of antibiotic administration, non-relapse mortality, Clostridiales, Clostridium cluster XIVa, indoxyl sulfate, graft-versus-host disease, overall survival
MeSH terms
Gastrointestinal Microbiome, Adult, Anti-Bacterial Agents, Clostridium, Female, Graft vs Host Disease, Humans, Infections, Male, Retrospective Studies, Risk Factors, Transplantation, Homologous, Survival Analysis, Treatment Outcome, Stem Cell Transplantation, Young Adult, Time-to-Treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review